Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-096008·SEG Opportunity Fund, LLC
Schedule 13G ownership disclosure
SILO PHARMA INC COM
Common Stock, $0.0001 par value per share · CUSIP: 82711P201
Event date: 2025-09-29
- Filing-level shares
- 952,381.00
- Percent of class
- 7.1%
- SEG Opportunity Fund, LLC
Shares: 952,381.00 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-096008
- Form type
- SCHEDULE 13G
- Filer
- SEG Opportunity Fund, LLC
- CIK
- CIK 2041952
- Filed
- Oct 03, 2025
- Reporting period
- Sep 29, 2025
- Description
- Schedule 13G beneficial ownership